As a result of increased innovation and modernization of therapeutic treatments, the diabetes market has matured significantly during the last 20 years. Because the condition is so common, and patient numbers are likely to continue to rise in the near future, drug developers have found it to be a lucrative market. As a result, according to Global Data, a prominent data and analytics organization, the global market size, as measured by pharmaceutical sales, has expanded sixfold since 2000. The global market for diabetes monitoring devices is expected to expand at a compound annual growth rate (CAGR) of 6.5 percent from $19.7 billion in 2020 to $27.0 billion in 2025.










Title : Vascular health with glucagon-like peptide-1 receptor agonists
Mahir Khalil Ibrahim Jallo, Thumbay University Hospital
Title : The prowess of Overripe Banana Sweetener (OBS) in enhancing nutritive values in food and ameliorating glycaemic responses in type 2 diabetes mellitus
Wan Rosli Wan Ishak, Universiti Sains Malaysia
Title : An intelligent hierarchical medical platform established upon high-quality datasets improves the effectiveness of glycemic management for patients across different levels of hospitals
Zhiheng Zhou, Southern Medical University
Title : Diabetes pathogenesis and prevention
Madhu S Malo, Stapgen LLC
Title : Effects of a structured education program on glycemic control in type 1 diabetes
Ana Paula Franco Pacheco, Estacio University of Brasília
Title : Differential diagnosis of diabetes in young and prevalence of LADA and LADY in young persons attending tertiary diabetes institute in Bengaluru, India
R Anil Kumar, Karnataka Institute of Endocrinology and Research
Title : Association between diabetes technology use and prevalent macrovascular disease in adults with type 1 diabetes: A cross-sectional analysis
Divanshi Trivedi, London Northwest Hospital NHS Foundation Trust
Title : Endocrine-specific diabetes risk modeling, glucose–insulin dynamics, and simulation-based metabolic review using the BVidAL clinical software suite
Abhishek Bansal, New Era Consultancy Services
Title : Using a multi-disciplinary clinic model to prevent diabetic foot ulcer recurrence
Kaishi Yang, Albert Einstein College of Medicine
Title : Shaping the future of diabetes care: New advancements in treatment, digital health and personalized patient care
Rupesh K Gautam, Amity Institute of Pharmacy